Skip to main content

Hologic Value Stock - Dividend - Research Selection

Hologic

ISIN: US4364401012 , WKN: 879100

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. It offers Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and related products, and accessories comprising digital and film-based mammography systems; computer-aided detection for mammography; minimally invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. In addition, it offers Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D, a software product that provides 2D images; Selenia digital mammography platform; and SecurView Workstation. Further, it provides SculpSure, MonaLisa Touch, Vectus diode, and Cellulaze laser devices; PicoSure and Icon aesthetic systems; MedLite, RevLite, Cynergy, Elite, and SmartLipo products; and system components. Additionally, it offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient\'s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Why Hologic (HOLX) Outpaced the Stock Market Today

2025-09-26
Hologic (HOLX) closed at $67.21 in the latest trading session, marking a +2.16% move from the prior day.

New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI

2025-09-26
MARLBOROUGH, Mass., September 26, 2025--New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI

HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?

2025-09-24
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.

Is Hologic Stock Underperforming the S&P 500?

2025-09-22
Hologic has underperformed the broader S&P 500 index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?

2025-09-22
Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains?

2025-09-22
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know

2025-09-19
Hologic (HOLX) concluded the recent trading session at $66.33, signifying a -2.84% move from its prior day's close.

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

2025-09-19
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Top Midday Stories: Nvidia to Invest $5 Billion in Intel; FTC Sues Live Nation for Alleged Illegal Ticket Resale Tactics

2025-09-18
All three major US stock indexes were up in late-morning trading Thursday, a day after the Federal R

Hologic (HOLX) Jumps 7.7% on Renewed Billion-Dollar Takeover Bid

2025-09-18
We recently published All-Time Rush: 8 of 10 Big Names Hit Fresh Record Highs. Hologic Inc. (NASDAQ:HOLX) is one of the best performers on Wednesday. Shares of Hologic Inc. rallied by 7.69 percent on Wednesday to close at $68.20 as investors repositioned portfolios amid reports that it was again in talks with two investment companies […]